PAPER
Enantioselective Reduction of Prochiral Ketones with a Biocatalyst
1885
(R)-Nonan-2-ol (2k)
Acknowledgment
[a]D25 = 12.8 (c 1.0, CHCl3).
Ch.S. thanks Director of IICT for financial assistance.
IR (neat): 3451, 2927, 2857, 1163, 770 cm–1.
1H NMR (200 MHz, CDCl3): d = 3.76 (m, 1 H), 1.47–1.21 (m, 15
H), 0.88 (d, J = 7.3 Hz, 3 H).
References
13C NMR (75 MHz, CDCl3): d = 13.8, 22.5, 23.1, 29.1, 29.5, 31.7,
(1) (a) Alfermann, A. Biocatalysis in Organic Synthesis;
39.1, 60.2, 67.7.
MS: m/z = 167 (M+ + Na).
Tramper, J.; van der Plas, H.; Linko, P., Eds.; Elsevier:
Amsterdam, 1985, 25. (b) Plant Cell Culture: A Practical
Approach; Dixon, R. A., Ed.; IRL Press: Eynsham, 1985.
(2) (a) Jones, J. B. In Comprehensive Organic Synthesis, Vol. 8;
Fleming, I.; Trost, B. M., Eds.; Pergamon Press: Oxford,
1991, 183. (b) Ward, O. P.; Young, C. S. Enzyme Microbiol.
Technol. 1998, 12, 482. (c)Nayori, R. AsymmetricCatalysis
in Organic Synthesis; Wiley: New York, 1994.
(2S,4S)-2-(4-Chlorophenyl)tetrahydro-2H-pyran-4-ol (3l)
[a]D25 –21.4, (c 1.0, CHCl3).
IR (neat): 3380, 2952, 2921, 2858, 1515, 1448, 1371, 1284, 1125,
1068, 1044, 985, 813 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.28 (d, J = 8.2 Hz, 2 H), 7.23 (d,
J = 8.2 Hz, 2 H), 4.24 (dd, J = 2.2, 11.7 Hz, 1 H), 4.14 (dd, J = 4.4,
11.7 Hz, 1 H), 3.87–3.78 (m, 1 H), 3.50 (td, J = 4.4, 12.4, 24.2 Hz,
1 H), 2.12 (m, 1 H), 2.05–1.89 (m, 2 H), 1.68–1.45 (m, 2 H).
13C NMR (75 MHz, CDCl3): d = 32.8, 40.6, 62.8, 64.2, 73.8, 125.8,
127.3, 128.3, 142.6.
(3) Ishihara, K.; Hamada, H.; Hirata, T.; Nakajima, N. J. Mol.
Catal. B: Enzym. 2003, 23, 145.
(4) Cordell, G. A.; Lemos, T. L. G.; Monte, F. J. Q.; de Mattos,
M. C. J. Nat. Prod. 2007, 70, 478.
(5) Blanchard, N.; Weghe, P. V. D. Org. Biomol. Chem. 2006,
4, 2348.
(6) (a) Akakabe, Y.; Takahashi, M.; Kamezawa, M.; Kikuchi,
K.; Tachibana, H.; Ohtani, T.; Naoshima, Y. J. Chem. Soc.,
Perkin Trans. 1 1995, 1295. (b) Baskar, B.; Ganesh, S.;
Lokeswari, T. S.; Chadka, A. J. Mol. Catal. B: Enzym. 2004,
27, 13.
MS: m/z = 213 (M+ + H).
(2R,4S)-2-(4-Chlorophenyl)tetrahydro-2H-pyran-4-ol (4l)
[a]D25 +15.7 (c 1.0, CHCl3).
(7) (a) Baldassarre, F.; Bertoni, G.; Chiappe, C.; Marioni, F.
J. Mol. Catal. B: Enzym. 2000, 11, 55. (b) Yadav, J. S.;
Reddy, P. T.; Hashim, S. R. Synlett 2000, 1049. (c) Yadav,
J. S.; Reddy, P. T.; Hashim, S. R. Synlett 2000, 473.
(d) Maczka, W. K.; Mironowicz, A. Tetrahedron:
Asymmetry 2002, 13, 2299.
IR (neat): 3382, 2940, 2842, 1489, 1448, 1409, 1364, 1301, 1249,
1163, 1142, 1085, 1050, 987, 691, 885, 823, 717, 689, 594 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.29 (d, J = 8.2 Hz, 2 H), 7.23 (d,
J = 8.2 Hz, 2 H), 4.72 (dd, J = 3.9, 10.4 Hz, 1 H), 4.34–4.22 (m, 1
H), 4.02 (td, J = 2.6, 11.7, 23.4 Hz, 1 H), 3.89 (td, J = 2.6, 11.7, 23.4
Hz, 1 H), 2.11–1.48 (m, 5 H).
(8) (a) Stampfer, W.; Kosjek, B.; Faber, K.; Kroutil, W. J. Org.
Chem. 2003, 68, 402. (b) Gröger, H.; Hummel, W.;
Rollmann, C.; Chamouleau, F.; Hüsken, H.; Werner, H.;
Wunderlich, C.; Abokitse, K.; Drauz, K.; Buchholz, S.
Tetrahedron 2004, 60, 633. (c) Edegger, K.; Stampfer, W.;
Seisser, B.; Faber, K.; Mayer, S. F.; Oehrlein, R.; Hafner, A.;
Kroutil, W. Eur. J. Org. Chem. 2006, 1904. (d) Yang, Z.-
H.; Zeng, R.; Yang, G.; Wang, Y.; Li, L.-Z.; Lv, Z.-S.; Yao,
M.; Lai, B. J. Ind. Microbiol. Biotechnol. 2008, 35, 1047.
(9) (a) Yadav, J. S.; Nanda, S.; Reddy, P. T.; Rao, A. B. J. Org.
Chem. 2002, 67, 3900. (b) Caron, D.; Coughlan, A. P.;
Simard, M.; Bernier, J.; Piche, Y.; Chenevert, R. Biotech.
Lett. 2005, 27, 713. (c) Scarpi, D.; Occhiato, E. G.; Guarna,
A. Tetrahedron: Asymmetry 2005, 16, 1479. (d) Mazczka,
W. K.; Mironowicz, A. Tetrahedron: Asymmetry 2004, 15,
1965. (e) Comasseto, J. V.; Omori, A. T.; Porto, A. L. M.;
Andrade, L. H. Tetrahedron Lett. 2004, 45, 473.
13C NMR (75 MHz, CDCl3): d = 32.8, 40.6, 62.8, 64.2, 73.8, 125.8,
127.3, 128.3, 142.6.
MS: m/z = 213 (M+ + H).
(2S,4S)-2-(Naphthalen-2-yl)tetrahydro-2H-pyran-4-ol (3m)
[a]D25 –21.2 (c 1.0, CHCl3).
IR (neat): 3433, 3028, 2908, 2842, 1457, 1342, 1208, 1081, 1012,
812, 748, 698, 477 cm–1.
1H NMR (200 MHz, CDCl3): d = 8.04 (d, J = 9.2 Hz, 1 H), 7.80 (dd,
J = 1.8, 7.1 Hz, 1 H), 7.71 (d, J = 8.3 Hz, 1 H), 7.60 (d, J = 6.4 Hz,
1 H), 7.50–7.37 (m, 3 H), 5.54 (dd, J = 1.8, 11.5 Hz, 1 H), 4.37 (m,
1 H), 4.20 (td, J = 2.2, 11.7, 24.3 Hz, 1 H), 4.02 (dd, J = 5.6, 12.0
Hz, 1 H), 2.23–1.98 (m, 2 H), 1.91 (td, J = 2.6, 11.5 Hz, 1 H), 1.75–
1.63 (m, 2 H).
13C NMR (75 MHz, CDCl3): d = 35.6, 42.2, 66.5, 68.5, 75.3, 123.0,
123.1, 125.42, 125.46, 125.9, 128.1, 128.8, 130.3, 133.7, 137.2.
MS: m/z = 252 (M+ + H + Na).
(f) Maczka, W. K.; Mironowicz, A. Tetrahedron:
Asymmetry 2002, 13, 2299.
(10) Kumaraswamy, G.; Ramesh, S. Green Chem. 2003, 5, 306.
(11) (a) Haslegrave, J. A.; Jones, J. B. J. Am. Chem. Soc. 1982,
104, 4667. (b) Harada, T.; Kurokawa, H.; Kagamihara, Y.;
Tanaka, S.; Inoue, A.; Oku, A. J. Org. Chem. 1992, 57,
1412. (c) Nunez, M. T.; Martin, V. S. J. Org. Chem. 1990,
55, 1928. (d) Yadav, J. S.; Reddy, B. V. S.; Padmavani, B.;
Venugopal, Ch.; Rao, A. B. Tetrahedron Lett. 2007, 48,
4613. (e) Yadav, J. S.; Reddy, B. V. S.; Sreelakshmi, Ch.;
Narayana Kumar, G. G. K. S.; Rao, A. B. Tetrahedron Lett.
2008, 49, 2768.
(2R,4S)-2-(Naphthalen-2-yl)tetrahydro-2H-pyran-4-ol (4m)
[a]D25 +18.6 (c 1.0, CHCl3).
IR (neat): 3428, 3056, 2923, 2850, 1465, 1361, 1245, 1081, 819,
748, 477 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.96 (d, J = 3.4 Hz, 1 H), 7.78 (dd,
J = 15.6, 7.8 Hz, 2 H), 7.60 (d, J = 6.5 Hz, 1 H), 7.54–7.37 (m, 3 H),
4.98 (d, J = 11.7 Hz, 1 H), 4.25 (dd, J = 11.7, 3.9 Hz, 1 H), 4.11–
3.91 (m, 1 H), 3.69 (td, J = 13.0, 2.6 Hz, 1 H), 2.36 (dt, J = 13.0, 2.6
Hz, 1 H), 2.12–1.92 (m, 2 H), 1.76–1.53 (m, 3 H).
(12) Prelog, V. Pure Appl. Chem. 1964, 9, 119.
13C NMR (75 MHz, CDCl3): d = 35.1, 42.9, 66.1, 67.8, 78.1, 122.3,
123.9, 124.2, 125.5, 125.7, 126.7, 127.3, 127.7, 129.2, 134.3.
MS: m/z = 252 (M+ + H + Na).
Synthesis 2009, No. 11, 1881–1885 © Thieme Stuttgart · New York